TY - JOUR
T1 - Cutting edge
T2 - Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes
AU - Bogiatzi, Sofia I.
AU - Fernandez, Isabel
AU - Bichet, Jean Christophe
AU - Marloie-Provost, Marie Annick
AU - Volpe, Elisabetta
AU - Sastre, Xavier
AU - Soumelis, Vassili
PY - 2007/3/15
Y1 - 2007/3/15
N2 - Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that strongly activates dendritic cells (DC) and can initiate allergic inflammation. The factors inducing the production of human TSLP are not known. In this study, we show that proinflammatory (TNF-α or IL-1α) and Th2 (IL-4 or IL-13) cytokines synergized to induce the production of TSLP in human skin explants. TSLP production in situ was restricted to epidermal keratinocytes of the suprabasal layer. TSLP production could not be inhibited by factors regulating Th2 inflammation, such as IL-10, TGF-β, or IFN-γ. Cytokine-treated skin culture supernatants induced the maturation of blood CD11c
+ DC in a TSLP-dependent manner. Our data provide the first evidence of TSLP induction and subsequent DC activation in human skin. Blocking TSLP-inducing cytokines could represent a novel strategy for the treatment of allergic diseases.
AB - Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine that strongly activates dendritic cells (DC) and can initiate allergic inflammation. The factors inducing the production of human TSLP are not known. In this study, we show that proinflammatory (TNF-α or IL-1α) and Th2 (IL-4 or IL-13) cytokines synergized to induce the production of TSLP in human skin explants. TSLP production in situ was restricted to epidermal keratinocytes of the suprabasal layer. TSLP production could not be inhibited by factors regulating Th2 inflammation, such as IL-10, TGF-β, or IFN-γ. Cytokine-treated skin culture supernatants induced the maturation of blood CD11c
+ DC in a TSLP-dependent manner. Our data provide the first evidence of TSLP induction and subsequent DC activation in human skin. Blocking TSLP-inducing cytokines could represent a novel strategy for the treatment of allergic diseases.
UR - http://www.scopus.com/inward/record.url?scp=33947244350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33947244350&partnerID=8YFLogxK
M3 - Article
C2 - 17339431
AN - SCOPUS:33947244350
SN - 0022-1767
VL - 178
SP - 3373
EP - 3377
JO - Journal of Immunology
JF - Journal of Immunology
IS - 6
ER -